The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

Charles L. Sawyers · Blood · 2002 · 1.2K citations

Pathology and genetics

J. N. Eble · Medical Entomology and Zoology · 2004 · 1.1K citations

Cancer Pathology, Oncopathology, Pathogenesis +7

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

Susan Branford, Zbigniew Rudzki, Sonya Walsh et al. · Blood · 2003 · 766 citations · Full text

Critical role for Gab2 in transformation by BCR/ABL

Martin Sattler, M. Golam Mohi, Yuri B. Pride et al. · Cancer Cell · 2002 · 358 citations · Full text

Ab-initio Method, Critical Role, Molecular Biology